Cargando…
SERPINE1 Overexpression Promotes Malignant Progression and Poor Prognosis of Gastric Cancer
The serine protease inhibitor clade E member 1 (SERPINE1) is a major inhibitor of tissue plasminogen activator and urokinase, and has been implicated in the development and progression of a variety of tumors. In this study, mRNA microarray and TCGA database were used to comprehensively analyze the u...
Autores principales: | Chen, Shujia, Li, Yuqiao, Zhu, Yinghui, Fei, Jiayue, Song, Liaoyuan, Sun, Guoyan, Guo, Lianyi, Li, Xiaofei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817868/ https://www.ncbi.nlm.nih.gov/pubmed/35132319 http://dx.doi.org/10.1155/2022/2647825 |
Ejemplares similares
-
IPO5 Mediates EMT and Promotes Esophageal Cancer Development through the RAS-ERK Pathway
por: Li, Meiyu, et al.
Publicado: (2022) -
SERPINE2 Overexpression Is Associated with Poor Prognosis of Urothelial Carcinoma
por: Chuang, Hao-Wen, et al.
Publicado: (2021) -
Immune-Related lncRNA Pairs Clinical Prognosis Model Construction for Hepatocellular Carcinoma
por: Zhu, Yinghui, et al.
Publicado: (2022) -
Serpin peptidase inhibitor clade A member 1-overexpression in gastric cancer promotes tumor progression in vitro and is associated with poor prognosis
por: Jiang, Longchang, et al.
Publicado: (2020) -
Serpin peptidase inhibitor, clade A member 3 (SERPINA3), is overexpressed in glioma and associated with poor prognosis in glioma patients
por: Luo, Dingyuan, et al.
Publicado: (2017)